Entry ID,Ligand,Value,Symbol,Type,Unit,PDB ID,Title,Structure Title,Stucture Keywords,Gene Name,EC Number,Annotation Identifier,Entity ID,Entry Id (Polymer Entity Identifiers),Target Protein,Accession Code(s),Database Name,Ligand Formula,Ligand MW,Ligand ID,Ligand Name,Ligand SMILES,Entity ID
7TXT,,,,,,7TXT,Structure of human serotonin transporter bound to small molecule '8090 in lipid nanodisc and NaCl,Structure of human serotonin transporter bound to small molecule '8090 in lipid nanodisc and NaCl,TRANSPORT PROTEIN,,,,1,7TXT,wildtype,,,C13 H14 F N3 S,263.334,KWC,"1-[4-(4-fluorophenyl)-1,3-thiazol-2-yl]piperazine",c1cc(ccc1c2csc(n2)N3CCNCC3)F,4
7U0Q,,,,,,7U0Q,SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02,SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02,VIRAL PROTEIN/IMMUNE SYSTEM,"S, 2",,"GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",1,7U0Q,wildtype,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,6
7U0X,,,,,,7U0X,SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-13,SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-13,VIRAL PROTEIN/IMMUNE SYSTEM,"S, 2",,"GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",1,7U0X,wildtype,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,5
7U8F,,,,,,7U8F,Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy.,Ternary complex structure of Cereblon-DDB1 bound to IKZF2(ZF2) and the molecular glue DKY709,LIGASE,"DDB1, XAP1",,"GO:0000781, GO:0080008, GO:0031464, GO:0031465, GO:0005737, GO:0070062, GO:0005615, GO:0005654, GO:0005634, GO:0032991, GO:0035861, GO:0097602, GO:0003684, GO:0003677, GO:0044877, GO:0030674, GO:0071987, GO:0006915, GO:0051702, GO:0006974, GO:0034644, GO:0006281, GO:0035234, GO:0035518, GO:0043066, GO:0051093, GO:2000242, GO:0006289, GO:0046726, GO:0045722, GO:0045732, GO:0045070, GO:0010498, GO:0043161, GO:0016567, GO:0042752, GO:1901990, GO:0048511, GO:0006511, GO:0070914, GO:0019076, GO:0016055, IPR004871, IPR018846, IPR031297, IPR015943, IPR036322, Q16531",2,7U8F,wildtype,Q16531,UniProt,C25 H27 N3 O3,417.5,LWK,"(3S)-3-[5-(1-benzylpiperidin-4-yl)-1-oxo-1,3-dihydro-2H-isoindol-2-yl]piperidine-2,6-dione",c1ccc(cc1)CN2CCC(CC2)c3ccc4c(c3)CN(C4=O)C5CCC(=O)NC5=O,5
7X0Z,,,,,,7X0Z,Structural insights into substrate recognition and translocation of human peroxisomal ABC transporter ALDP.,Cryo-EM structure of human ABCD1 E630Q in the presence of ATP and Magnesium in outward-facing state,STRUCTURAL PROTEIN,"ABCD1, ALD","3.1.2, 7.6.2","GO:0005737, GO:0005829, GO:0005789, GO:0005765, GO:0016020, GO:0031966, GO:0048471, GO:0005778, GO:0005777, GO:0015607, GO:0047617, GO:0043531, GO:0005524, GO:0016887, GO:0042626, GO:0019899, GO:0042802, GO:0005324, GO:0046982, GO:0042803, GO:0036109, GO:0006635, GO:0030497, GO:0055089, GO:0043651, GO:0042758, GO:0015910, GO:0043217, GO:1900016, GO:1903427, GO:1990535, GO:0015919, GO:0007031, GO:0032000, GO:2001280, GO:1900407, GO:0031998, GO:0051900, GO:0002082, GO:0055092, GO:0042760, GO:0000038, GO:0036113, IPR003593, IPR011527, IPR036640, IPR003439, IPR017871, IPR031237, IPR005283, IPR027417, P33897, TRANSMEMBRANE PROTEINS: ALPHA-HELICAL.ATP Binding Cassette (ABC) Transporters.peroxisomal fatty acid transporter ABCD1, also known as adrenoleukodystrophy protein (ALDP), C26:0 bound, Transmembrane.Alpha-helical polytopic.ABC transporters.ABC transporter D familiy (ABCD), Generic PDBTM",1,7X0Z,mutant,P33897,UniProt,C10 H16 N5 O13 P3,507.181,ATP,ADENOSINE-5'-TRIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,3
7X1W,,,,,,7X1W,Structural insights into substrate recognition and translocation of human peroxisomal ABC transporter ALDP.,Cryo-EM structure of human ABCD1 E630Q in the presence of ATP in inward-facing state,STRUCTURAL PROTEIN,"ABCD1, ALD","3.1.2, 7.6.2","GO:0005737, GO:0005829, GO:0005789, GO:0005765, GO:0016020, GO:0031966, GO:0048471, GO:0005778, GO:0005777, GO:0015607, GO:0047617, GO:0043531, GO:0005524, GO:0016887, GO:0042626, GO:0019899, GO:0042802, GO:0005324, GO:0046982, GO:0042803, GO:0036109, GO:0006635, GO:0030497, GO:0055089, GO:0043651, GO:0042758, GO:0015910, GO:0043217, GO:1900016, GO:1903427, GO:1990535, GO:0015919, GO:0007031, GO:0032000, GO:2001280, GO:1900407, GO:0031998, GO:0051900, GO:0002082, GO:0055092, GO:0042760, GO:0000038, GO:0036113, IPR003593, IPR011527, IPR036640, IPR003439, IPR017871, IPR031237, IPR005283, IPR027417, P33897, TRANSMEMBRANE PROTEINS: ALPHA-HELICAL.ATP Binding Cassette (ABC) Transporters.peroxisomal fatty acid transporter ABCD1, also known as adrenoleukodystrophy protein (ALDP), C26:0 bound, Transmembrane.Alpha-helical polytopic.ABC transporters.ABC transporter D familiy (ABCD), Generic PDBTM",1,7X1W,mutant,P33897,UniProt,C10 H16 N5 O13 P3,507.181,ATP,ADENOSINE-5'-TRIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,2
7X2H,,,,,,7X2H,Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab,Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab,VIRAL PROTEIN/IMMUNE SYSTEM,,,,1,7X2H,wildtype,,,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,4
7X3N,,,,,,7X3N,Structural determination of an antibody that specifically recognizes polyethylene glycol with a terminal methoxy group,Crystal structure of anti-mPEG h15-2b Fab,IMMUNE SYSTEM,,,,1,7X3N,wildtype,,,C13 H28 O7,296.357,P15,"2,5,8,11,14,17-HEXAOXANONADECAN-19-OL",COCCOCCOCCOCCOCCOCCO,3
7X93,,,,,,7X93,Intentional generation of sars-cov-2 therapeutic antibodies with broad spectrum,The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765,VIRAL PROTEIN,"S, 2",,"GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",1,7X93,mutant,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,6
7XDB,,,,,,7XDB,Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5.,Cryo-EM structure of SARS-CoV-2 Omicron Spike protein in complex with BA7208 fab,VIRAL PROTEIN,"S, 2",,"GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",2,7XDB,mutant,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,5
7XDE,,,,,,7XDE,Suppression of the human malic enzyme 2 modifies energy metabolism and inhibits cellular respiration,Cryo-EM structures of human mitochondrial NAD(P)+-dependent malic enzyme in apo form,HYDROLASE,ME2,1.1.1.38,"GO:0043231, GO:0005759, GO:0005739, GO:0009055, GO:0004471, GO:0004473, GO:0004470, GO:0046872, GO:0051287, GO:0008948, GO:0006108, GO:0006090, GO:1902031, IPR046346, IPR015884, IPR012301, IPR037062, IPR012302, IPR001891, IPR036291, P23368",1,7XDE,wildtype,P23368,UniProt,C21 H27 N7 O14 P2,663.425,NAD,NICOTINAMIDE-ADENINE-DINUCLEOTIDE,c1cc(c[n+](c1)C2C(C(C(O2)COP(=O)([O-])OP(=O)(O)OCC3C(C(C(O3)n4cnc5c4ncnc5N)O)O)O)O)C(=O)N,2
7XDF,,,,,,7XDF,Suppression of the human malic enzyme 2 modifies energy metabolism and inhibits cellular respiration,Cryo-EM structures of human mitochondrial NAD(P)+-dependent malic enzyme in a ternary complex with NAD+ and allosteric inhibitor EA,HYDROLASE,ME2,1.1.1.38,"GO:0043231, GO:0005759, GO:0005739, GO:0009055, GO:0004471, GO:0004473, GO:0004470, GO:0046872, GO:0051287, GO:0008948, GO:0006108, GO:0006090, GO:1902031, IPR046346, IPR015884, IPR012301, IPR037062, IPR012302, IPR001891, IPR036291, P23368",1,7XDF,wildtype,P23368,UniProt,C21 H27 N7 O14 P2,663.425,NAD,NICOTINAMIDE-ADENINE-DINUCLEOTIDE,c1cc(c[n+](c1)C2C(C(C(O2)COP(=O)([O-])OP(=O)(O)OCC3C(C(C(O3)n4cnc5c4ncnc5N)O)O)O)O)C(=O)N,2
7XDF,,,,,,7XDF,Suppression of the human malic enzyme 2 modifies energy metabolism and inhibits cellular respiration,Cryo-EM structures of human mitochondrial NAD(P)+-dependent malic enzyme in a ternary complex with NAD+ and allosteric inhibitor EA,HYDROLASE,ME2,1.1.1.38,"GO:0043231, GO:0005759, GO:0005739, GO:0009055, GO:0004471, GO:0004473, GO:0004470, GO:0046872, GO:0051287, GO:0008948, GO:0006108, GO:0006090, GO:1902031, IPR046346, IPR015884, IPR012301, IPR037062, IPR012302, IPR001891, IPR036291, P23368",1,7XDF,wildtype,P23368,UniProt,C23 H16 O6,388.37,JBR,4-[(3-carboxy-2-oxidanyl-naphthalen-1-yl)methyl]-3-oxidanyl-naphthalene-2-carboxylic acid,c1ccc2c(c1)cc(c(c2Cc3c4ccccc4cc(c3O)C(=O)O)O)C(=O)O,3
7XDG,,,,,,7XDG,Suppression of the human malic enzyme 2 modifies energy metabolism and inhibits cellular respiration,Cryo-EM structures of human mitochondrial NAD(P)+-dependent malic enzyme in a ternary complex with NAD+ and allosteric inhibitor MDSA,HYDROLASE,ME2,1.1.1.38,"GO:0043231, GO:0005759, GO:0005739, GO:0009055, GO:0004471, GO:0004473, GO:0004470, GO:0046872, GO:0051287, GO:0008948, GO:0006108, GO:0006090, GO:1902031, IPR046346, IPR015884, IPR012301, IPR037062, IPR012302, IPR001891, IPR036291, P23368",1,7XDG,wildtype,P23368,UniProt,C21 H27 N7 O14 P2,663.425,NAD,NICOTINAMIDE-ADENINE-DINUCLEOTIDE,c1cc(c[n+](c1)C2C(C(C(O2)COP(=O)([O-])OP(=O)(O)OCC3C(C(C(O3)n4cnc5c4ncnc5N)O)O)O)O)C(=O)N,2
7XDG,,,,,,7XDG,Suppression of the human malic enzyme 2 modifies energy metabolism and inhibits cellular respiration,Cryo-EM structures of human mitochondrial NAD(P)+-dependent malic enzyme in a ternary complex with NAD+ and allosteric inhibitor MDSA,HYDROLASE,ME2,1.1.1.38,"GO:0043231, GO:0005759, GO:0005739, GO:0009055, GO:0004471, GO:0004473, GO:0004470, GO:0046872, GO:0051287, GO:0008948, GO:0006108, GO:0006090, GO:1902031, IPR046346, IPR015884, IPR012301, IPR037062, IPR012302, IPR001891, IPR036291, P23368",1,7XDG,wildtype,P23368,UniProt,C15 H12 O6,288.252,D5S,5-[(3-carboxy-4-oxidanyl-phenyl)methyl]-2-oxidanyl-benzoic acid,c1cc(c(cc1Cc2ccc(c(c2)C(=O)O)O)C(=O)O)O,3
7XDK,,,,,,7XDK,Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5.,Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7054 and BA7125 fab,VIRAL PROTEIN,,,,2,7XDK,wildtype,,,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,7
7XDL,,,,,,7XDL,Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5.,Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7208 and BA7125 fab,VIRAL PROTEIN,"S, 2",,"GO:0044173, GO:0020002, GO:0016020, GO:0019031, GO:0055036, GO:0046789, GO:0042802, GO:0075509, GO:0039654, GO:0019064, GO:0061025, GO:0046598, GO:0019065, GO:0046813, GO:0039587, GO:0039502, GO:0046718, GO:0019058, IPR032500, IPR042578, IPR043607, IPR043473, IPR043002, IPR044341, IPR018548, IPR044366, IPR036326, IPR002552, IPR044873, IPR044874, P0DTC2",1,7XDL,wildtype,P0DTC2,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,7
7XEC,,,,,,7XEC,Structural insights into substrate recognition and translocation of human peroxisomal ABC transporter ALDP.,Cryo-EM structure of human ABCD1 E630Q in the presence of ATP in inward-facing state 2,STRUCTURAL PROTEIN,"ABCD1, ALD","3.1.2, 7.6.2","GO:0005737, GO:0005829, GO:0005789, GO:0005765, GO:0016020, GO:0031966, GO:0048471, GO:0005778, GO:0005777, GO:0015607, GO:0047617, GO:0043531, GO:0005524, GO:0016887, GO:0042626, GO:0019899, GO:0042802, GO:0005324, GO:0046982, GO:0042803, GO:0036109, GO:0006635, GO:0030497, GO:0055089, GO:0043651, GO:0042758, GO:0015910, GO:0043217, GO:1900016, GO:1903427, GO:1990535, GO:0015919, GO:0007031, GO:0032000, GO:2001280, GO:1900407, GO:0031998, GO:0051900, GO:0002082, GO:0055092, GO:0042760, GO:0000038, GO:0036113, IPR003593, IPR011527, IPR036640, IPR003439, IPR017871, IPR031237, IPR005283, IPR027417, P33897, TRANSMEMBRANE PROTEINS: ALPHA-HELICAL.ATP Binding Cassette (ABC) Transporters.peroxisomal fatty acid transporter ABCD1, also known as adrenoleukodystrophy protein (ALDP), C26:0 bound, Transmembrane.Alpha-helical polytopic.ABC transporters.ABC transporter D familiy (ABCD), Generic PDBTM",1,7XEC,mutant,P33897,UniProt,C10 H16 N5 O13 P3,507.181,ATP,ADENOSINE-5'-TRIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,2
7XKI,,,,,,7XKI,Cryo-EM structures of human Cx36/GJD2 neuronal gap junction channel.,Human Cx36/GJD2 (N-terminal deletion BRIL-fused mutant) gap junction channel in soybean lipids (D6 symmetry),MEMBRANE PROTEIN,"GJD2, GJA9",,"GO:0042597, GO:0009055, GO:0020037, GO:0005506, IPR009155, IPR010980, GO:0005922, GO:0005886, GO:0045202, GO:0005243, GO:0007267, GO:0007268, GO:0019228, GO:0007601, IPR000500, IPR002260, IPR019570, IPR017990, IPR013092, IPR038359, Q9UKL4, Transmembrane.Alpha-helical polytopic.Tetraspan junctional complexes.Connexin, Generic PDBTM",1,7XKI,mutant,Q9UKL4,UniProt,C36 H72 N O8 P,677.933,MC3,"1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE",CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,2
7XKT,,,,,,7XKT,Cryo-EM structures of human Cx36/GJD2 neuronal gap junction channel.,Human Cx36/GJD2 (BRIL-fused mutant) gap junction channel in detergents at 2.2 Angstroms resolution,MEMBRANE PROTEIN,"GJD2, GJA9",,"GO:0042597, GO:0009055, GO:0020037, GO:0005506, IPR009155, IPR010980, GO:0005922, GO:0005886, GO:0045202, GO:0005243, GO:0007267, GO:0007268, GO:0019228, GO:0007601, IPR000500, IPR002260, IPR019570, IPR017990, IPR013092, IPR038359, Q9UKL4, Transmembrane.Alpha-helical polytopic.Tetraspan junctional complexes.Connexin, Generic PDBTM",1,7XKT,mutant,Q9UKL4,UniProt,C36 H72 N O8 P,677.933,MC3,"1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE",CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,2
7XKT,,,,,,7XKT,Cryo-EM structures of human Cx36/GJD2 neuronal gap junction channel.,Human Cx36/GJD2 (BRIL-fused mutant) gap junction channel in detergents at 2.2 Angstroms resolution,MEMBRANE PROTEIN,cybC,,"GO:0042597, GO:0009055, GO:0020037, GO:0005506, IPR009155, IPR010980, GO:0005922, GO:0005886, GO:0045202, GO:0005243, GO:0007267, GO:0007268, GO:0019228, GO:0007601, IPR000500, IPR002260, IPR019570, IPR017990, IPR013092, IPR038359, Q9UKL4, Transmembrane.Alpha-helical polytopic.Tetraspan junctional complexes.Connexin, Generic PDBTM",1,7XKT,mutant,P0ABE7,UniProt,C31 H50 O4,486.726,Y01,CHOLESTEROL HEMISUCCINATE,CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)CCC(=O)O)C)C,3
7XKT,,,,,,7XKT,Cryo-EM structures of human Cx36/GJD2 neuronal gap junction channel.,Human Cx36/GJD2 (BRIL-fused mutant) gap junction channel in detergents at 2.2 Angstroms resolution,MEMBRANE PROTEIN,"GJD2, GJA9",,"GO:0042597, GO:0009055, GO:0020037, GO:0005506, IPR009155, IPR010980, GO:0005922, GO:0005886, GO:0045202, GO:0005243, GO:0007267, GO:0007268, GO:0019228, GO:0007601, IPR000500, IPR002260, IPR019570, IPR017990, IPR013092, IPR038359, Q9UKL4, Transmembrane.Alpha-helical polytopic.Tetraspan junctional complexes.Connexin, Generic PDBTM",1,7XKT,mutant,P0ABE7,,C38 H75 O10 P,722.97,LHG,"1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE",CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCCCCCCCCCC,4
7XNH,,,,,,7XNH,Cryo-EM structures of human Cx36/GJD2 neuronal gap junction channel.,Human Cx36/GJD2 gap junction channel with pore-lining N-terminal helices in soybean lipids,MEMBRANE PROTEIN,"GJD2, GJA9",,"GO:0005922, GO:0005886, GO:0045202, GO:0005243, GO:0007267, GO:0007268, GO:0019228, GO:0007601, IPR000500, IPR002260, IPR019570, IPR017990, IPR013092, IPR038359, Q9UKL4, Transmembrane.Alpha-helical polytopic.Tetraspan junctional complexes.Connexin, Generic PDBTM",1,7XNH,wildtype,Q9UKL4,UniProt,C36 H72 N O8 P,677.933,MC3,"1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE",CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,2
7XNV,,,,,,7XNV,Cryo-EM structures of human Cx36/GJD2 neuronal gap junction channel.,Structurally hetero-junctional human Cx36/GJD2 gap junction channel in soybean lipids (C6 symmetry),MEMBRANE PROTEIN,"GJD2, GJA9",,"GO:0005922, GO:0005886, GO:0045202, GO:0005243, GO:0007267, GO:0007268, GO:0019228, GO:0007601, IPR000500, IPR002260, IPR019570, IPR017990, IPR013092, IPR038359, Q9UKL4, Transmembrane.Alpha-helical polytopic.Tetraspan junctional complexes.Connexin, Generic PDBTM",1,7XNV,wildtype,Q9UKL4,UniProt,C36 H72 N O8 P,677.933,MC3,"1,2-DIMYRISTOYL-RAC-GLYCERO-3-PHOSPHOCHOLINE",CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC,2
7Y09,,,,,,7Y09,Cryo-EM structure of human IgM-Fc in complex with the J chain and the DBL domain of DBLMSP,Cryo-EM structure of human IgM-Fc in complex with the J chain and the DBL domain of DBLMSP,IMMUNE SYSTEM,,,"GO:0016020, GO:0046789, IPR042202, IPR008602, IPR010784",1,7Y09,wildtype,C5HX06,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,5
7Y4A,,,,,,7Y4A,Targeting Ras-binding domain of ELMO3 by computational nanobody design.,Crystal structure of human ELMO3 RBD-RhoG complex,SIGNALING PROTEIN,"ELMO1, KIAA0281",,"GO:0005737, GO:0005829, GO:0032045, GO:0016020, GO:0005886, GO:0017124, GO:0030036, GO:0007015, GO:0030029, GO:0006915, GO:0016477, GO:0048870, GO:0006911, GO:0016601, GO:0050790, IPR011989, IPR016024, IPR030715, IPR024574, IPR006816, IPR011993, IPR001849, Q92556",2,7Y4A,wildtype,Q92556,UniProt,C10 H15 N5 O11 P2,443.201,GDP,GUANOSINE-5'-DIPHOSPHATE,c1nc2c(n1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N,5
7YAG,,,,,,7YAG,Cryo-EM structures of human SPCA1a reveal the mechanism of Ca 2+ /Mn 2+ transport into the Golgi apparatus.,CryoEM structure of SPCA1a in E1-Ca-AMPPCP state subclass 1,TRANSPORT PROTEIN,"ATP2C1, KIAA1347, PMR1L, HUSSY-28",7.2.2.10,"GO:0033106, GO:0005783, GO:0005794, GO:0032580, GO:0000139, GO:0016020, GO:0005886, GO:0005802, GO:0005524, GO:0016887, GO:0005509, GO:0030145, GO:0046872, GO:0005388, GO:0015662, GO:0140613, GO:0070588, GO:0006816, GO:0016339, GO:0006874, GO:0030026, GO:0008544, GO:0032468, GO:0032472, GO:0034220, GO:0006828, GO:0042998, GO:0043123, GO:0098629, IPR006068, IPR004014, IPR023299, IPR018303, IPR023298, IPR008250, IPR036412, IPR023214, IPR006413, IPR001757, IPR044492, P98194, Transmembrane.Alpha-helical polytopic.P-type ATPase (P-ATPase).P-ATPase, Generic PDBTM",1,7YAG,wildtype,P98194,UniProt,C11 H18 N5 O12 P3,505.208,ACP,PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(CP(=O)(O)O)O)O)O)N,3
7YAH,,,,,,7YAH,Cryo-EM structures of human SPCA1a reveal the mechanism of Ca 2+ /Mn 2+ transport into the Golgi apparatus.,CryoEM structure of SPCA1a in E1-Ca-AMPPCP state subclass 2,TRANSPORT PROTEIN,"ATP2C1, KIAA1347, PMR1L, HUSSY-28",7.2.2.10,"GO:0033106, GO:0005783, GO:0005794, GO:0032580, GO:0000139, GO:0016020, GO:0005886, GO:0005802, GO:0005524, GO:0016887, GO:0005509, GO:0030145, GO:0046872, GO:0005388, GO:0015662, GO:0140613, GO:0070588, GO:0006816, GO:0016339, GO:0006874, GO:0030026, GO:0008544, GO:0032468, GO:0032472, GO:0034220, GO:0006828, GO:0042998, GO:0043123, GO:0098629, IPR006068, IPR004014, IPR023299, IPR018303, IPR023298, IPR008250, IPR036412, IPR023214, IPR006413, IPR001757, IPR044492, P98194, Transmembrane.Alpha-helical polytopic.P-type ATPase (P-ATPase).P-ATPase, Generic PDBTM",1,7YAH,wildtype,P98194,UniProt,C11 H18 N5 O12 P3,505.208,ACP,PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(CP(=O)(O)O)O)O)O)N,3
7YAI,,,,,,7YAI,Cryo-EM structures of human SPCA1a reveal the mechanism of Ca 2+ /Mn 2+ transport into the Golgi apparatus.,CryoEM structure of SPCA1a in E1-Ca-AMPPCP state subclass 3,TRANSPORT PROTEIN,"ATP2C1, KIAA1347, PMR1L, HUSSY-28",7.2.2.10,"GO:0033106, GO:0005783, GO:0005794, GO:0032580, GO:0000139, GO:0016020, GO:0005886, GO:0005802, GO:0005524, GO:0016887, GO:0005509, GO:0030145, GO:0046872, GO:0005388, GO:0015662, GO:0140613, GO:0070588, GO:0006816, GO:0016339, GO:0006874, GO:0030026, GO:0008544, GO:0032468, GO:0032472, GO:0034220, GO:0006828, GO:0042998, GO:0043123, GO:0098629, IPR006068, IPR004014, IPR023299, IPR018303, IPR023298, IPR008250, IPR036412, IPR023214, IPR006413, IPR001757, IPR044492, P98194, Transmembrane.Alpha-helical polytopic.P-type ATPase (P-ATPase).P-ATPase, Generic PDBTM",1,7YAI,wildtype,P98194,UniProt,C11 H18 N5 O12 P3,505.208,ACP,PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(CP(=O)(O)O)O)O)O)N,3
7YAJ,,,,,,7YAJ,Cryo-EM structures of human SPCA1a reveal the mechanism of Ca 2+ /Mn 2+ transport into the Golgi apparatus.,CryoEM structure of SPCA1a in E1-Mn-AMPPCP state subclass 1,TRANSPORT PROTEIN,"ATP2C1, KIAA1347, PMR1L, HUSSY-28",7.2.2.10,"GO:0033106, GO:0005783, GO:0005794, GO:0032580, GO:0000139, GO:0016020, GO:0005886, GO:0005802, GO:0005524, GO:0016887, GO:0005509, GO:0030145, GO:0046872, GO:0005388, GO:0015662, GO:0140613, GO:0070588, GO:0006816, GO:0016339, GO:0006874, GO:0030026, GO:0008544, GO:0032468, GO:0032472, GO:0034220, GO:0006828, GO:0042998, GO:0043123, GO:0098629, IPR006068, IPR004014, IPR023299, IPR018303, IPR023298, IPR008250, IPR036412, IPR023214, IPR006413, IPR001757, IPR044492, P98194, Transmembrane.Alpha-helical polytopic.P-type ATPase (P-ATPase).P-ATPase, Generic PDBTM",1,7YAJ,wildtype,P98194,UniProt,C11 H18 N5 O12 P3,505.208,ACP,PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(CP(=O)(O)O)O)O)O)N,3
7YG2,,,,,,7YG2,Cryo-EM structure of human IgM-Fc in complex with the J chain and the DBL domain of DBLMSP2,Cryo-EM structure of human IgM-Fc in complex with the J chain and the DBL domain of DBLMSP2,IMMUNE SYSTEM,DBLMSP2,,"GO:0016020, GO:0046789, IPR042202, IPR008602",1,7YG2,wildtype,A0A0A7MCY3,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,5
7YK7,,,,,,7YK7,Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4).,Cryo-EM structure of the DC591053-bound human relaxin family peptide receptor 4 (RXFP4)-Gi complex,STRUCTURAL PROTEIN,GNG2,,"GO:0005834, GO:0016020, GO:0005886, GO:0031681, GO:0003924, GO:0007191, GO:0071870, GO:0071380, GO:0007186, IPR015898, IPR036284, IPR001770, Transmembrane.Alpha-helical polytopic.Rhodopsin-like receptors and pumps.G-protein coupled receptors, family A, Generic PDBTM",1,7YK7,mutant,P63212,UniProt,C28 H35 N3 O5,493.595,IYM,"[(1S)-7-ethoxy-6-methoxy-1-[2-(5-methoxy-1H-indol-3-yl)ethyl]-3,4-dihydro-1H-isoquinolin-2-yl]-morpholin-4-yl-methanone",CCOc1cc2c(cc1OC)CCN(C2CCc3c[nH]c4c3cc(cc4)OC)C(=O)N5CCOCC5,6
7YS6,,,,,,7YS6,Structural insights into constitutive activity of 5-HT6 receptor,Cryo-EM structure of the Serotonin 6 (5-HT6) receptor-DNGs-scFv16 complex,MEMBRANE PROTEIN,HTR6,,"GO:0005929, GO:0030425, GO:0005886, GO:0045202, GO:0004993, GO:0004969, GO:0030594, GO:0021795, GO:0007268, GO:0007187, GO:0032008, IPR002232, IPR000276, IPR017452, P50406, TRANSMEMBRANE PROTEINS: ALPHA-HELICAL.G Protein-Coupled Receptors: Class A.5-HT<sub>6</sub> serotonin receptor G<sub>s</sub>-scFv16 complex, Transmembrane.Alpha-helical polytopic.Rhodopsin-like receptors and pumps.G-protein coupled receptors, family A, Generic PDBTM",1,7YS6,wildtype,P50406,UniProt,C10 H12 N2 O,176.215,SRO,SEROTONIN,c1cc2c(cc1O)c(c[nH]2)CCN,6
8A5V,,,,,,8A5V,L-serine biosynthesis in the human central nervous system: Structure and function of phosphoserine aminotransferase.,Crystal structure of the human phosposerine aminotransferase (PSAT),TRANSFERASE,"PSAT1, PSA",2.6.1.52,"GO:0005737, GO:0005829, GO:0070062, GO:0042802, GO:0004648, GO:0030170, GO:0006564, GO:0008615, IPR000192, IPR020578, IPR022278, IPR015424, IPR015421, IPR015422, Q9Y617",2,8A5V,wildtype,Q9Y617,UniProt,C8 H13 N2 O5 P,248.173,PMP,4'-DEOXY-4'-AMINOPYRIDOXAL-5'-PHOSPHATE,Cc1c(c(c(cn1)COP(=O)(O)O)CN)O,4
8A5W,,,,,,8A5W,L-serine biosynthesis in the human central nervous system: Structure and function of phosphoserine aminotransferase.,Crystal structure of the human phosphoserine aminotransferase (PSAT) in complex with O-phosphoserine,TRANSFERASE,"PSAT1, PSA",2.6.1.52,"GO:0005737, GO:0005829, GO:0070062, GO:0042802, GO:0004648, GO:0030170, GO:0006564, GO:0008615, IPR000192, IPR020578, IPR022278, IPR015424, IPR015421, IPR015422, Q9Y617",1,8A5W,wildtype,Q9Y617,UniProt,C8 H13 N2 O5 P,248.173,PMP,4'-DEOXY-4'-AMINOPYRIDOXAL-5'-PHOSPHATE,Cc1c(c(c(cn1)COP(=O)(O)O)CN)O,7
8A5W,,,,,,8A5W,L-serine biosynthesis in the human central nervous system: Structure and function of phosphoserine aminotransferase.,Crystal structure of the human phosphoserine aminotransferase (PSAT) in complex with O-phosphoserine,TRANSFERASE,"PSAT1, PSA",2.6.1.52,"GO:0005737, GO:0005829, GO:0070062, GO:0042802, GO:0004648, GO:0030170, GO:0006564, GO:0008615, IPR000192, IPR020578, IPR022278, IPR015424, IPR015421, IPR015422, Q9Y617",2,8A5W,wildtype,Q9Y617,UniProt,C11 H16 N2 O11 P2,414.199,E1U,(2S)-2-[(E)-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylideneamino]-3-phosphonooxy-propanoic acid,Cc1c(c(c(cn1)COP(=O)(O)O)C=NC(COP(=O)(O)O)C(=O)O)O,4
8A5W,,,,,,8A5W,L-serine biosynthesis in the human central nervous system: Structure and function of phosphoserine aminotransferase.,Crystal structure of the human phosphoserine aminotransferase (PSAT) in complex with O-phosphoserine,TRANSFERASE,"PSAT1, PSA",2.6.1.52,"GO:0005737, GO:0005829, GO:0070062, GO:0042802, GO:0004648, GO:0030170, GO:0006564, GO:0008615, IPR000192, IPR020578, IPR022278, IPR015424, IPR015421, IPR015422, Q9Y617",3,8A5W,wildtype,Q9Y617,UniProt,C17 H30 N4 O12 P2,544.387,U93,(2~{S})-2-[[(~{R})-[[(5~{S})-5-azanyl-6-oxidanylidene-hexyl]amino]-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methyl]amino]-3-phosphonooxy-propanoic acid,Cc1c(c(c(cn1)COP(=O)(O)O)C(NCCCCC(C=O)N)NC(COP(=O)(O)O)C(=O)O)O,5
8A5W,,,,,,8A5W,L-serine biosynthesis in the human central nervous system: Structure and function of phosphoserine aminotransferase.,Crystal structure of the human phosphoserine aminotransferase (PSAT) in complex with O-phosphoserine,TRANSFERASE,"PSAT1, PSA",2.6.1.52,"GO:0005737, GO:0005829, GO:0070062, GO:0042802, GO:0004648, GO:0030170, GO:0006564, GO:0008615, IPR000192, IPR020578, IPR022278, IPR015424, IPR015421, IPR015422, Q9Y617",3,8A5W,wildtype,Q9Y617,UniProt,C3 H8 N O6 P,185.072,SEP,PHOSPHOSERINE,C(C(C(=O)O)N)OP(=O)(O)O,6
8AFO,,,,,,8AFO,X-ray structure and function of fibronectin domains two and three of the neural cell adhesion molecule L1.,Structure of fibronectin 2 and 3 of L1CAM at 2.0 Angstrom,CELL ADHESION,"L1CAM, CAML1, MIC5",,"GO:0030424, GO:0044295, GO:0009986, GO:0062023, GO:0030425, GO:0005925, GO:0043025, GO:0005886, GO:0008046, GO:0019904, GO:0061564, GO:0007411, GO:0007155, GO:0016477, GO:0007160, GO:0006935, GO:0007156, GO:0007399, GO:0031175, GO:0045773, GO:0050808, IPR003961, IPR036116, IPR007110, IPR036179, IPR013783, IPR013098, IPR003599, IPR003598, IPR026966, P32004",1,8AFO,wildtype,P32004,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,3
8AFP,,,,,,8AFP,X-ray structure and function of fibronectin domains two and three of the neural cell adhesion molecule L1.,Structure of fibronectin 2 and 3 of L1CAM at 3.0 Angstrom,CELL ADHESION,"L1CAM, CAML1, MIC5",,"GO:0030424, GO:0044295, GO:0009986, GO:0062023, GO:0030425, GO:0005925, GO:0043025, GO:0005886, GO:0008046, GO:0019904, GO:0061564, GO:0007411, GO:0007155, GO:0016477, GO:0007160, GO:0006935, GO:0007156, GO:0007399, GO:0031175, GO:0045773, GO:0050808, IPR003961, IPR036116, IPR007110, IPR036179, IPR013783, IPR013098, IPR003599, IPR003598, IPR026966, P32004",1,8AFP,wildtype,P32004,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,2
8BC8,,,,,,8BC8,Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.,Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 18,HYDROLASE,"SNRNP200, ASCC3L1, HELIC2, KIAA0788",3.6.4.13,"GO:0071013, GO:0016020, GO:0005654, GO:0005634, GO:0005681, GO:0071006, GO:0071005, GO:0046540, GO:0005682, GO:0005524, GO:0016887, GO:0004386, GO:0042802, GO:0003723, GO:0003724, GO:0000354, GO:0000398, GO:0001649, GO:0000388, IPR041094, IPR035892, IPR011545, IPR014001, IPR001650, IPR014756, IPR027417, IPR004179, IPR036388, IPR036390, O75643",1,8BC8,wildtype,O75643,UniProt,C6 H8 N2 O3 S,188.204,QB6,3-azanyl-4-oxidanyl-benzenesulfonamide,c1cc(c(cc1S(=O)(=O)N)N)O,3
8BC9,,,,,,8BC9,Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.,Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 24,HYDROLASE,"SNRNP200, ASCC3L1, HELIC2, KIAA0788",3.6.4.13,"GO:0071013, GO:0016020, GO:0005654, GO:0005634, GO:0005681, GO:0071006, GO:0071005, GO:0046540, GO:0005682, GO:0005524, GO:0016887, GO:0004386, GO:0042802, GO:0003723, GO:0003724, GO:0000354, GO:0000398, GO:0001649, GO:0000388, IPR041094, IPR035892, IPR011545, IPR014001, IPR001650, IPR014756, IPR027417, IPR004179, IPR036388, IPR036390, O75643",1,8BC9,wildtype,O75643,UniProt,C6 H7 N O3 S,173.19,A09,N-hydroxybenzenesulfonamide,c1ccc(cc1)S(=O)(=O)NO,3
8BCA,,,,,,8BCA,Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.,Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 26,HYDROLASE,"PRPF8, PRPC8",,"GO:0071013, GO:0016020, GO:0016607, GO:0005654, GO:0005634, GO:0071006, GO:0071007, GO:0071005, GO:0046540, GO:0005682, GO:0070530, GO:0097157, GO:0003723, GO:0030619, GO:0030620, GO:0030623, GO:0017070, GO:0071222, GO:0071356, GO:0006397, GO:0000398, GO:0008380, GO:0000375, GO:0000244, IPR000555, IPR037518, IPR012591, IPR012592, IPR012984, IPR027652, IPR021983, IPR043173, IPR043172, IPR019581, IPR042516, IPR019580, IPR012337, IPR019582, Q6P2Q9",2,8BCA,wildtype,Q6P2Q9,UniProt,C8 H13 N3 O2 S,215.273,Q96,3-azanyl-~{N}-methyl-4-(methylamino)benzenesulfonamide,CNc1ccc(cc1N)S(=O)(=O)NC,3
8BCB,,,,,,8BCB,Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.,Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 34,HYDROLASE,"SNRNP200, ASCC3L1, HELIC2, KIAA0788",3.6.4.13,"GO:0071013, GO:0016020, GO:0005654, GO:0005634, GO:0005681, GO:0071006, GO:0071005, GO:0046540, GO:0005682, GO:0005524, GO:0016887, GO:0004386, GO:0042802, GO:0003723, GO:0003724, GO:0000354, GO:0000398, GO:0001649, GO:0000388, IPR041094, IPR035892, IPR011545, IPR014001, IPR001650, IPR014756, IPR027417, IPR004179, IPR036388, IPR036390, O75643",1,8BCB,wildtype,O75643,UniProt,C6 H8 N2 O2 S,172.205,SAN,SULFANILAMIDE,c1cc(ccc1N)S(=O)(=O)N,4
8BCC,,,,,,8BCC,Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.,Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 39,HYDROLASE,"SNRNP200, ASCC3L1, HELIC2, KIAA0788",3.6.4.13,"GO:0071013, GO:0016020, GO:0005654, GO:0005634, GO:0005681, GO:0071006, GO:0071005, GO:0046540, GO:0005682, GO:0005524, GO:0016887, GO:0004386, GO:0042802, GO:0003723, GO:0003724, GO:0000354, GO:0000398, GO:0001649, GO:0000388, IPR041094, IPR035892, IPR011545, IPR014001, IPR001650, IPR014756, IPR027417, IPR004179, IPR036388, IPR036390, O75643",1,8BCC,wildtype,O75643,UniProt,C6 H7 N O3 S,173.19,QAU,3-oxidanylbenzenesulfonamide,c1cc(cc(c1)S(=O)(=O)N)O,3
8BCD,,,,,,8BCD,Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.,Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 50,HYDROLASE,"SNRNP200, ASCC3L1, HELIC2, KIAA0788",3.6.4.13,"GO:0071013, GO:0016020, GO:0005654, GO:0005634, GO:0005681, GO:0071006, GO:0071005, GO:0046540, GO:0005682, GO:0005524, GO:0016887, GO:0004386, GO:0042802, GO:0003723, GO:0003724, GO:0000354, GO:0000398, GO:0001649, GO:0000388, IPR041094, IPR035892, IPR011545, IPR014001, IPR001650, IPR014756, IPR027417, IPR004179, IPR036388, IPR036390, O75643",1,8BCD,wildtype,O75643,UniProt,C7 H7 N O2 S3,233.331,QB0,phenylsulfonylcarbamodithioic acid,c1ccc(cc1)S(=O)(=O)NC(=S)S,3
8BCE,,,,,,8BCE,Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.,Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 76,HYDROLASE,"SNRNP200, ASCC3L1, HELIC2, KIAA0788",3.6.4.13,"GO:0071013, GO:0016020, GO:0005654, GO:0005634, GO:0005681, GO:0071006, GO:0071005, GO:0046540, GO:0005682, GO:0005524, GO:0016887, GO:0004386, GO:0042802, GO:0003723, GO:0003724, GO:0000354, GO:0000398, GO:0001649, GO:0000388, IPR041094, IPR035892, IPR011545, IPR014001, IPR001650, IPR014756, IPR027417, IPR004179, IPR036388, IPR036390, O75643",1,8BCE,wildtype,O75643,UniProt,C7 H9 N O3 S,187.216,B09,N-methoxybenzenesulfonamide,CONS(=O)(=O)c1ccccc1,3
8BCF,,,,,,8BCF,Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.,Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 78,HYDROLASE,"PRPF8, PRPC8",,"GO:0071013, GO:0016020, GO:0016607, GO:0005654, GO:0005634, GO:0071006, GO:0071007, GO:0071005, GO:0046540, GO:0005682, GO:0070530, GO:0097157, GO:0003723, GO:0030619, GO:0030620, GO:0030623, GO:0017070, GO:0071222, GO:0071356, GO:0006397, GO:0000398, GO:0008380, GO:0000375, GO:0000244, IPR000555, IPR037518, IPR012591, IPR012592, IPR012984, IPR027652, IPR021983, IPR043173, IPR043172, IPR019581, IPR042516, IPR019580, IPR012337, IPR019582, Q6P2Q9",2,8BCF,wildtype,Q6P2Q9,UniProt,C8 H11 N O3 S,201.243,Q8Z,~{N}-methoxy-~{N}-methyl-benzenesulfonamide,CN(OC)S(=O)(=O)c1ccccc1,4
8BCG,,,,,,8BCG,Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.,Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and compound 86,HYDROLASE,"SNRNP200, ASCC3L1, HELIC2, KIAA0788",3.6.4.13,"GO:0071013, GO:0016020, GO:0005654, GO:0005634, GO:0005681, GO:0071006, GO:0071005, GO:0046540, GO:0005682, GO:0005524, GO:0016887, GO:0004386, GO:0042802, GO:0003723, GO:0003724, GO:0000354, GO:0000398, GO:0001649, GO:0000388, IPR041094, IPR035892, IPR011545, IPR014001, IPR001650, IPR014756, IPR027417, IPR004179, IPR036388, IPR036390, O75643",1,8BCG,wildtype,O75643,UniProt,C8 H10 Cl N O3 S,235.688,Q9I,4-chloranyl-~{N}-methoxy-~{N}-methyl-benzenesulfonamide,CN(OC)S(=O)(=O)c1ccc(cc1)Cl,3
8BCH,,,,,,8BCH,Conformation-dependent ligand hot spots in the spliceosomal RNA helicase BRR2.,Human Brr2 Helicase Region in complex with Sulfaguanidine,HYDROLASE,"SNRNP200, ASCC3L1, HELIC2, KIAA0788",3.6.4.13,"GO:0071013, GO:0016020, GO:0005654, GO:0005634, GO:0005681, GO:0071006, GO:0071005, GO:0046540, GO:0005682, GO:0005524, GO:0016887, GO:0004386, GO:0042802, GO:0003723, GO:0003724, GO:0000354, GO:0000398, GO:0001649, GO:0000388, IPR041094, IPR035892, IPR011545, IPR014001, IPR001650, IPR014756, IPR027417, IPR004179, IPR036388, IPR036390, O75643",1,8BCH,wildtype,O75643,UniProt,C7 H10 N4 O2 S,214.245,QA9,1-(4-aminophenyl)sulfonylguanidine,c1cc(ccc1N)S(=O)(=O)NC(=N)N,2
8BZY,,,,,,8BZY,Structures of ferroportin in complex with its specific inhibitor vamifeport.,Structure of SLC40/ferroportin in complex with vamifeport and synthetic nanobody Sy3 in occluded conformation,TRANSPORT PROTEIN,"SLC40A1, FPN1, IREG1, SLC11A3, MSTP079",,"GO:0016323, GO:0005737, GO:0005829, GO:0005654, GO:0005886, GO:0008021, GO:0015093, GO:0042802, GO:0005381, GO:0046872, GO:0017046, GO:0006915, GO:0006879, GO:0003158, GO:0051649, GO:1903988, GO:0034755, GO:0002260, GO:0060586, GO:0043066, GO:0045944, GO:0034395, GO:0060345, GO:0006366, IPR009716, IPR036259, Q9NP59, Transmembrane.Alpha-helical polytopic.Major Facilitator Superfamily (MFS).Ferroportin, Generic PDBTM",2,8BZY,wildtype,Q9NP59,UniProt,C21 H21 F N6 O2,408.429,SZU,"2-[2-[2-(1~{H}-benzimidazol-2-yl)ethylamino]ethyl]-~{N}-[(3-fluoranylpyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide",c1ccc2c(c1)[nH]c(n2)CCNCCc3nc(co3)C(=O)NCc4c(cccn4)F,4
8C03,,,,,,8C03,Structures of ferroportin in complex with its specific inhibitor vamifeport.,Structure of SLC40/ferroportin in complex with vamifeport and synthetic nanobody Sy12 in outward-facing conformation,TRANSPORT PROTEIN,"SLC40A1, FPN1, IREG1, SLC11A3, MSTP079",,"GO:0016323, GO:0005737, GO:0005829, GO:0005654, GO:0005886, GO:0008021, GO:0015093, GO:0042802, GO:0005381, GO:0046872, GO:0017046, GO:0006915, GO:0006879, GO:0003158, GO:0051649, GO:1903988, GO:0034755, GO:0002260, GO:0060586, GO:0043066, GO:0045944, GO:0034395, GO:0060345, GO:0006366, IPR009716, IPR036259, Q9NP59, Transmembrane.Alpha-helical polytopic.Major Facilitator Superfamily (MFS).Ferroportin, Generic PDBTM",1,8C03,wildtype,Q9NP59,UniProt,C21 H21 F N6 O2,408.429,SZU,"2-[2-[2-(1~{H}-benzimidazol-2-yl)ethylamino]ethyl]-~{N}-[(3-fluoranylpyridin-2-yl)methyl]-1,3-oxazole-4-carboxamide",c1ccc2c(c1)[nH]c(n2)CCNCCc3nc(co3)C(=O)NCc4c(cccn4)F,2
8C3N,,,,,,8C3N,A Recombinant Approach For Stapled Peptide Discovery Yields Inhibitors of the RAD51 Recombinase,Stapled peptide SP30 in complex with humanised RadA mutant HumRadA22,RECOMBINATION,"radA, PF1926",,"GO:0005524, GO:0140664, GO:0003684, GO:0006310, GO:0006281, IPR003593, IPR013632, IPR011938, IPR016467, IPR010995, IPR003583, IPR027417, IPR033925, IPR020588, IPR020587",1,8C3N,mutant,O74036,UniProt,C8 H13 N3,151.209,RF6,"4,6-diethylpyrimidin-2-amine",CCc1cc(nc(n1)N)CC,5
8DBB,,,,,,8DBB,"2,5-Pyridinedicarboxylic acid is a bioactive and highly selective inhibitor of D-dopachrome tautomerase.","Crystal structure of DDT with the selective inhibitor 2,5-Pyridinedicarboxylic Acid",LYASE/INHIBITOR,DDT,4.1.1.84,"GO:0005737, GO:0070062, GO:0005615, GO:0005126, GO:0033981, GO:0004167, GO:0050178, GO:0042438, GO:0010760, GO:0070374, GO:0050729, GO:0032760, IPR001398, IPR019829, IPR014347, P30046",1,8DBB,wildtype,P30046,UniProt,C7 H5 N O4,167.119,R3K,"pyridine-2,5-dicarboxylic acid",c1cc(ncc1C(=O)O)C(=O)O,2
8DEY,,,,,,8DEY,Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy.,"Ternary complex structure of Cereblon-DDB1 bound to IKZF2(ZF2,3) and the molecular glue DKY709",LIGASE,"IKZF2, HELIOS, ZNFN1A2",,"GO:0005634, GO:0003700, GO:0046872, GO:0000978, GO:0006357, IPR036236, IPR013087, Q9UKS7",3,8DEY,wildtype,Q9UKS7,UniProt,C25 H27 N3 O3,417.5,LWK,"(3S)-3-[5-(1-benzylpiperidin-4-yl)-1-oxo-1,3-dihydro-2H-isoindol-2-yl]piperidine-2,6-dione",c1ccc(cc1)CN2CCC(CC2)c3ccc4c(c3)CN(C4=O)C5CCC(=O)NC5=O,5
8F8E,,,,,,8F8E,Crystal structure of the WDR domain of human DCAF1 in complex with OICR-8268 compound,Crystal structure of the WDR domain of human DCAF1 in complex with OICR-8268 compound,TRANSFERASE/INHIBITOR,"DCAF1, KIAA0800, RIP, VPRBP",2.7.11.1,"GO:0080008, GO:0005737, GO:0001650, GO:0005654, GO:0005634, GO:0005524, GO:1990244, GO:0030331, GO:0106310, GO:0030183, GO:0035212, GO:0006325, GO:0000122, GO:0043687, GO:0016567, GO:0033151, IPR011989, IPR016024, IPR006594, IPR033270, IPR015943, IPR036322, Q9Y4B6",1,8F8E,mutant,Q9Y4B6,UniProt,C19 H14 Cl2 F2 N4 O2,439.243,XJI,(3P)-N-[(1S)-3-amino-1-(3-chloro-4-fluorophenyl)-3-oxopropyl]-3-(4-chloro-2-fluorophenyl)-1H-pyrazole-4-carboxamide,c1cc(c(cc1C(CC(=O)N)NC(=O)c2c[nH]nc2c3ccc(cc3F)Cl)Cl)F,2
8FN0,,,,,,8FN0,Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator.,CryoEM structure of Go-coupled NTSR1 with a biased allosteric modulator,MEMBRANE PROTEIN,"Ntsr1, Ntsr",,"GO:0030424, GO:0043679, GO:0009986, GO:0005737, GO:0009898, GO:0030425, GO:0043198, GO:0043197, GO:0005783, GO:0005794, GO:0045121, GO:0005739, GO:0044309, GO:0043025, GO:0043204, GO:0005886, GO:0032280, GO:0045202, GO:0043195, GO:0016492, GO:0004930, GO:0042802, GO:0044877, GO:0008344, GO:0070779, GO:0050965, GO:0007186, GO:0071545, GO:0098712, GO:0007612, GO:0043066, GO:0051280, GO:0003085, GO:0007218, GO:0043065, GO:0090238, GO:2001259, GO:0014054, GO:0010628, GO:0014049, GO:0097151, GO:0060732, GO:0051092, GO:0051281, GO:0098900, GO:0003254, GO:0043576, GO:0051930, GO:0033993, GO:0001659, IPR000276, IPR017452, IPR003985, IPR003984, P20789, TRANSMEMBRANE PROTEINS: ALPHA-HELICAL.G Protein-Coupled Receptors: Class A.NTSR1 neurotensin receptor - G<sub>oA</sub> complex, Transmembrane.Alpha-helical polytopic.Rhodopsin-like receptors and pumps.G-protein coupled receptors, family A, Generic PDBTM",1,8FN0,mutant,P20789,UniProt,C26 H31 F N4 O2,450.548,SRW,2-[{2-(1-fluorocyclopropyl)-4-[4-(2-methoxyphenyl)piperidin-1-yl]quinazolin-6-yl}(methyl)amino]ethan-1-ol,CN(CCO)c1ccc2c(c1)c(nc(n2)C3(CC3)F)N4CCC(CC4)c5ccccc5OC,7
8FT6,,,,,,8FT6,Decreasing the flexibility of the TELSAM-target protein linker and omitting the cleavable fusion tag improves crystal order and diffraction limits.,"The von Willebrand factor A domain of human capillary morphogenesis gene II, flexibly fused to the 1TEL crystallization chaperone, Ala-Ala linker variant, SUMO tag-free preparation.",PEPTIDE BINDING PROTEIN,"ANTXR2, CMG2",,"GO:0009986, GO:0005789, GO:0010008, GO:0005576, GO:0005886, GO:0046872, GO:0004888, GO:1901998, IPR017360, IPR008399, IPR008400, IPR002035, IPR036465, GO:0000785, GO:0005829, GO:0005730, GO:0005634, GO:0001228, GO:0003700, GO:0000981, GO:0001227, GO:0019904, GO:0000978, GO:0000977, GO:0030154, GO:0071425, GO:0097152, GO:0000122, GO:0022008, GO:0006357, GO:0007296, IPR000418, IPR046328, IPR003118, IPR013761, IPR036388, IPR036390, P58335, P41212",1,8FT6,mutant,P58335,UniProt,I,126.904,IOD,IODIDE ION,[I-],3
8G46,,,,,,8G46,Template-assisted covalent modification of DCAF16 underlies activity of BRD4 molecular glue degraders.,Cryo-EM structure of DDB1deltaB-DDA1-DCAF16-BRD4(BD2)-MMH2,LIGASE,"DDB1, XAP1",,"GO:0000781, GO:0080008, GO:0031464, GO:0031465, GO:0005737, GO:0070062, GO:0005615, GO:0005654, GO:0005634, GO:0032991, GO:0035861, GO:0097602, GO:0003684, GO:0003677, GO:0044877, GO:0030674, GO:0071987, GO:0006915, GO:0051702, GO:0006974, GO:0034644, GO:0006281, GO:0035234, GO:0035518, GO:0043066, GO:0051093, GO:2000242, GO:0006289, GO:0046726, GO:0045722, GO:0045732, GO:0045070, GO:0010498, GO:0043161, GO:0016567, GO:0042752, GO:1901990, GO:0048511, GO:0006511, GO:0070914, GO:0019076, GO:0016055, IPR004871, IPR018846, IPR031297, IPR015943, IPR036322, Q16531",1,8G46,wildtype,Q16531,UniProt,C25 H31 N5 O4 S2,529.675,YK3,"tert-butyl [(6S,10P)-4-{4-[(ethanesulfonyl)amino]phenyl}-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetate",CCS(=O)(=O)Nc1ccc(cc1)C2=NC(c3nnc(n3-c4c2c(c(s4)C)C)C)CC(=O)OC(C)(C)C,6
8G59,,,,,,8G59,Unsaturated bond recognition leads to biased signal in a fatty acid receptor.,Cryo-EM structure of the TUG891 bound GPR120-Giq complex,MEMBRANE PROTEIN,GNB1,,"GO:0005737, GO:0005829, GO:0070062, GO:1903561, GO:0005834, GO:0005765, GO:0016020, GO:0097381, GO:0005886, GO:0045202, GO:0003924, GO:0051020, GO:0044877, GO:0030159, GO:0007191, GO:0008283, GO:0071870, GO:0071380, GO:0007213, GO:0007186, GO:0007200, GO:0007265, GO:0060041, GO:0050909, GO:0007165, IPR020472, IPR001632, IPR016346, IPR015943, IPR001680, IPR019775, IPR036322, P62873",1,8G59,mutant,P62873,UniProt,C23 H21 F O3,364.409,YN9,"3-{4-[(4-fluoro-4'-methyl[1,1'-biphenyl]-2-yl)methoxy]phenyl}propanoic acid",Cc1ccc(cc1)c2ccc(cc2COc3ccc(cc3)CCC(=O)O)F,6
8GCY,,,,,,8GCY,Co-crystal structure of CBL-B in complex with N-Aryl isoindolin-1-one inhibitor,Co-crystal structure of CBL-B in complex with N-Aryl isoindolin-1-one inhibitor,LIGASE/LIGASE INHIBITOR,"CBLB, RNF56, Nbla00127",2.3.2.27,"GO:0005829, GO:0045121, GO:0005654, GO:0005886, GO:0005509, GO:0001784, GO:0030971, GO:0017124, GO:0061630, GO:0008270, GO:0035739, GO:0006955, GO:0035556, GO:2000562, GO:0007175, GO:0050860, GO:0006607, GO:0018193, GO:0045732, GO:0031398, GO:0002669, GO:0030163, GO:0043087, GO:2000583, GO:0043393, GO:0007165, GO:0002870, GO:0050852, IPR024162, IPR014741, IPR036537, IPR003153, IPR014742, IPR039520, IPR024159, IPR011992, IPR036860, IPR015940, IPR001841, IPR013083, IPR017907, Q13191",1,8GCY,wildtype,Q13191,UniProt,C30 H34 F3 N5 O,537.619,Z3N,"2-{3-[(1s,3R)-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl}-6-{[(3S)-3-methylpiperidin-1-yl]methyl}-4-(trifluoromethyl)-2,3-dihydro-1H-isoindol-1-one",CC1CCCN(C1)Cc2cc3c(c(c2)C(F)(F)F)CN(C3=O)c4cccc(c4)C5(CC(C5)C)c6nncn6C,3
8GSU,,,,,,8GSU,Mutagenic analysis of actin reveals the mechanism of His161 flipping that triggers ATP hydrolysis.,Crystal structure of human cardiac alpha actin (WT_ADP-Pi) in complex with fragmin F1 domain,CONTRACTILE PROTEIN,"ACTC1, ACTC",3.6.4,"GO:0005884, GO:0072562, GO:0044297, GO:0005737, GO:0005829, GO:0005869, GO:0070062, GO:0005615, GO:0030175, GO:0005925, GO:0098978, GO:0031674, GO:0030027, GO:0016020, GO:0030017, GO:0005524, GO:0016787, GO:0000146, GO:0017022, GO:0007015, GO:0030048, GO:0033275, GO:0031032, GO:0055008, GO:0055003, GO:0060047, GO:0090131, GO:0043066, GO:0010628, GO:0030240, IPR004000, IPR020902, IPR004001, IPR043129, P68032",1,8GSU,wildtype,P68032,UniProt,C10 H15 N5 O10 P2,427.201,ADP,ADENOSINE-5'-DIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N,3
8GSW,,,,,,8GSW,Mutagenic analysis of actin reveals the mechanism of His161 flipping that triggers ATP hydrolysis.,Crystal structure of human cardiac alpha actin A108G mutant (AMPPNP state) in complex with fragmin F1 domain,CONTRACTILE PROTEIN,"ACTC1, ACTC",3.6.4,"GO:0005884, GO:0072562, GO:0044297, GO:0005737, GO:0005829, GO:0005869, GO:0070062, GO:0005615, GO:0030175, GO:0005925, GO:0098978, GO:0031674, GO:0030027, GO:0016020, GO:0030017, GO:0005524, GO:0016787, GO:0000146, GO:0017022, GO:0007015, GO:0030048, GO:0033275, GO:0031032, GO:0055008, GO:0055003, GO:0060047, GO:0090131, GO:0043066, GO:0010628, GO:0030240, IPR004000, IPR020902, IPR004001, IPR043129, P68032",1,8GSW,mutant,P68032,UniProt,C10 H17 N6 O12 P3,506.196,ANP,PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(NP(=O)(O)O)O)O)O)N,3
8GT1,,,,,,8GT1,Mutagenic analysis of actin reveals the mechanism of His161 flipping that triggers ATP hydrolysis.,Crystal structure of human cardiac alpha actin A108G mutant (ADP-Pi state) in complex with fragmin F1 domain,CONTRACTILE PROTEIN,,,"GO:0051015, IPR029006, IPR007123, IPR007122",2,8GT1,mutant,Q94707,UniProt,C10 H15 N5 O10 P2,427.201,ADP,ADENOSINE-5'-DIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N,3
8GT2,,,,,,8GT2,Mutagenic analysis of actin reveals the mechanism of His161 flipping that triggers ATP hydrolysis.,Crystal structure of human cardiac alpha actin P109A mutant (AMPPNP state) in complex with fragmin F1 domain,CONTRACTILE PROTEIN,"ACTC1, ACTC",3.6.4,"GO:0051015, IPR029006, IPR007123, IPR007122",2,8GT2,mutant,Q94707,UniProt,C10 H17 N6 O12 P3,506.196,ANP,PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(NP(=O)(O)O)O)O)O)N,3
8GT3,,,,,,8GT3,Mutagenic analysis of actin reveals the mechanism of His161 flipping that triggers ATP hydrolysis.,Crystal structure of human cardiac alpha actin P109A mutant (ADP-Pi state) in complex with fragmin F1 domain,CONTRACTILE PROTEIN,"ACTC1, ACTC",3.6.4,"GO:0051015, IPR029006, IPR007123, IPR007122",2,8GT3,mutant,Q94707,UniProt,C10 H15 N5 O10 P2,427.201,ADP,ADENOSINE-5'-DIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N,3
8GT4,,,,,,8GT4,Mutagenic analysis of actin reveals the mechanism of His161 flipping that triggers ATP hydrolysis.,Crystal structure of human cardiac alpha actin Q137A mutant (AMPPNP state) in complex with fragmin F1 domain,CONTRACTILE PROTEIN,"ACTC1, ACTC",3.6.4,"GO:0051015, IPR029006, IPR007123, IPR007122",2,8GT4,mutant,Q94707,UniProt,C10 H17 N6 O12 P3,506.196,ANP,PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(NP(=O)(O)O)O)O)O)N,3
8GT5,,,,,,8GT5,Mutagenic analysis of actin reveals the mechanism of His161 flipping that triggers ATP hydrolysis.,Crystal structure of human cardiac alpha actin Q137A mutant (ADP-Pi state) in complex with fragmin F1 domain,CONTRACTILE PROTEIN,"ACTC1, ACTC",3.6.4,"GO:0005884, GO:0072562, GO:0044297, GO:0005737, GO:0005829, GO:0005869, GO:0070062, GO:0005615, GO:0030175, GO:0005925, GO:0098978, GO:0031674, GO:0030027, GO:0016020, GO:0030017, GO:0005524, GO:0016787, GO:0000146, GO:0017022, GO:0007015, GO:0030048, GO:0033275, GO:0031032, GO:0055008, GO:0055003, GO:0060047, GO:0090131, GO:0043066, GO:0010628, GO:0030240, IPR004000, IPR020902, IPR004001, IPR043129, P68032",1,8GT5,mutant,P68032,UniProt,C10 H15 N5 O10 P2,427.201,ADP,ADENOSINE-5'-DIPHOSPHATE,c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N,3
8GYW,,,,,,8GYW,Making membranes: Structure of human choline/ethanolamine phosphotransferase 1,Cryo-EM structure of human CEPT1 complexed with CDP-choline,LIPID BINDING PROTEIN,"CEPT1, PRO1101","2.7.8.1, 2.7.8.2, 2.7.8.22","GO:0005789, GO:0005794, GO:0016020, GO:0031965, GO:0047359, GO:0004142, GO:0004307, GO:0046872, GO:0006629, GO:0006646, IPR000462, IPR043130, IPR014472, Q9Y6K0, Transmembrane.Alpha-helical polytopic.Choline/ethanolamine phosphotransferase.Choline/ethanolamine phosphotransferase 1, Generic PDBTM",1,8GYW,wildtype,Q9Y6K0,UniProt,C14 H26 N4 O11 P2,488.324,CDC,[2-CYTIDYLATE-O'-PHOSPHONYLOXYL]-ETHYL-TRIMETHYL-AMMONIUM,C[N+](C)(C)CCOP(=O)([O-])OP(=O)(O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,3
8GYX,,,,,,8GYX,Making membranes: Structure of human choline/ethanolamine phosphotransferase 1,Cryo-EM structure of human CEPT1,LIPID BINDING PROTEIN,"CEPT1, PRO1101","2.7.8.1, 2.7.8.2, 2.7.8.22","GO:0005789, GO:0005794, GO:0016020, GO:0031965, GO:0047359, GO:0004142, GO:0004307, GO:0046872, GO:0006629, GO:0006646, IPR000462, IPR043130, IPR014472, Q9Y6K0, Transmembrane.Alpha-helical polytopic.Choline/ethanolamine phosphotransferase.Choline/ethanolamine phosphotransferase 1, Generic PDBTM",1,8GYX,wildtype,Q9Y6K0,UniProt,C42 H82 N O8 P,760.076,POV,(2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC,2
8GZ1,,,,,,8GZ1,"Structure of human Na V 1.6 channel reveals Na + selectivity and pore blockade by 4,9-anhydro-tetrodotoxin.","Cryo-EM structure of human NaV1.6/beta1/beta2,apo state",MEMBRANE PROTEIN,SCN1B,,"GO:0005576, GO:0014704, GO:0033268, GO:0043204, GO:0005886, GO:0030315, GO:0001518, GO:0019871, GO:0017080, GO:0044325, GO:0005244, GO:0005248, GO:0086006, GO:0086062, GO:0007411, GO:0061337, GO:0086002, GO:0060048, GO:0007155, GO:0021966, GO:0040011, GO:0051899, GO:0086012, GO:0086047, GO:0019227, GO:0010976, GO:0010765, GO:0060371, GO:0086091, GO:2000649, GO:0060307, GO:0035725, IPR036179, IPR013783, IPR013106, IPR027098, IPR044568, Q07699, TRANSMEMBRANE PROTEINS: ALPHA-HELICAL.Channels: Potassium, Sodium, & Proton Ion-Selective.Na<sub>V</sub>1.6 with 棺1 and 棺2 subunits, apo state, Transmembrane.Alpha-helical polytopic.Ion channel (VIC) superfamily.Voltage-gated calcium and sodium channels, Generic PDBTM",1,8GZ1,wildtype,Q07699,UniProt,C8 H15 N O6,221.208,NAG,2-acetamido-2-deoxy-beta-D-glucopyranose,CC(=O)NC1C(C(C(OC1O)CO)O)O,5
8GZ2,,,,,,8GZ2,"Structure of human Na V 1.6 channel reveals Na + selectivity and pore blockade by 4,9-anhydro-tetrodotoxin.","Cryo-EM structure of human NaV1.6/beta1/beta2-4,9-anhydro-tetrodotoxin",MEMBRANE PROTEIN,"SCN8A, MED",,"GO:0030424, GO:0043194, GO:0030054, GO:0031410, GO:0016020, GO:0033268, GO:0005886, GO:0001518, GO:0030018, GO:0005524, GO:0005244, GO:0005248, GO:0086010, GO:0042552, GO:0007399, GO:0019228, GO:0007422, GO:0034765, GO:0035725, GO:0006814, IPR005821, IPR000048, IPR008054, IPR001696, IPR044564, IPR010526, IPR024583, IPR043203, IPR027359, Q9UQD0, TRANSMEMBRANE PROTEINS: ALPHA-HELICAL.Channels: Potassium, Sodium, & Proton Ion-Selective.Na<sub>V</sub>1.6 with 棺1 and 棺2 subunits, apo state, Transmembrane.Alpha-helical polytopic.Ion channel (VIC) superfamily.Voltage-gated calcium and sodium channels, Generic PDBTM",2,8GZ2,wildtype,Q9UQD0,UniProt,C11 H15 N3 O7,301.253,WMK,"(1R,2S,3S,4R,5R,9S,11S,12S,14R)-7-amino-2,4,12-trihydroxy-2-(hydroxymethyl)-10,13,15-trioxa-6,8-diazapentacyclo[7.4.1.1~3,12~.0~5,11~.0~5,14~]pentadec-7-en-8-ium (non-preferred name)",C(C1(C2C3C4N=C(NC35C(C1OC(C5O4)(O2)O)O)N)O)O,6
8HKP,,,,,,8HKP,Cryo-EM structures of human Cx36/GJD2 neuronal gap junction channel.,Structurally hetero-junctional human Cx36/GJD2 gap junction channel in detergents (C6 symmetry),MEMBRANE PROTEIN,"GJD2, GJA9",,"GO:0005922, GO:0005886, GO:0045202, GO:0005243, GO:0007267, GO:0007268, GO:0019228, GO:0007601, IPR000500, IPR002260, IPR019570, IPR017990, IPR013092, IPR038359, Q9UKL4, Transmembrane.Alpha-helical polytopic.Tetraspan junctional complexes.Connexin, Generic PDBTM",1,8HKP,wildtype,Q9UKL4,UniProt,C47 H88 O22,1005.188,AV0,"2-decyl-2-{[(4-O-alpha-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]methyl}dodecyl
4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside",CCCCCCCCCCC(CCCCCCCCCC)(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O)COC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)CO)O)O)O)O)O,2
8ID4,,,,,,8ID4,Unsaturated bond recognition leads to biased signal in a fatty acid receptor.,Cryo-EM structure of the linoleic acid bound GPR120-Gi complex,MEMBRANE PROTEIN,"FFAR4, GPR120, GPR129, O3FAR1, PGR4",,"GO:0060170, GO:0005929, GO:0030139, GO:0010008, GO:0005765, GO:0005886, GO:1990763, GO:0005504, GO:0004930, GO:0008527, GO:0050873, GO:0007186, GO:0036321, GO:0046879, GO:0006954, GO:0043066, GO:0001818, GO:0050728, GO:0032691, GO:0090275, GO:0007200, GO:0090336, GO:0043950, GO:0120162, GO:0007204, GO:0070374, GO:0070094, GO:0045669, GO:0010827, GO:0050872, IPR000276, IPR017452, Q5NUL3, TRANSMEMBRANE PROTEINS: ALPHA-HELICAL.G Protein-Coupled Receptors: Class A.GPR120 free fatty-acid receptor 4 (FFAR4) - G<sub>iq</sub> complex, with bound TUG891, Transmembrane.Alpha-helical polytopic.Rhodopsin-like receptors and pumps.G-protein coupled receptors, family A, Generic PDBTM",1,8ID4,wildtype,Q5NUL3,UniProt,C18 H32 O2,280.445,EIC,LINOLEIC ACID,CCCCCC=CCC=CCCCCCCCC(=O)O,6
8ID9,,,,,,8ID9,Unsaturated bond recognition leads to biased signal in a fatty acid receptor.,Cryo-EM structure of the eicosapentaenoic acid bound GPR120-Gi complex,MEMBRANE PROTEIN,GNB1,,"GO:0005737, GO:0005829, GO:0070062, GO:1903561, GO:0005834, GO:0005765, GO:0016020, GO:0097381, GO:0005886, GO:0045202, GO:0003924, GO:0051020, GO:0044877, GO:0030159, GO:0007191, GO:0008283, GO:0071870, GO:0071380, GO:0007213, GO:0007186, GO:0007200, GO:0007265, GO:0060041, GO:0050909, GO:0007165, IPR020472, IPR001632, IPR016346, IPR015943, IPR001680, IPR019775, IPR036322, P62873",1,8ID9,wildtype,P62873,UniProt,C20 H30 O2,302.451,EPA,"5,8,11,14,17-EICOSAPENTAENOIC ACID",CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,6
